ctDNA-Based Adjuvant Chemotherapy for High-Risk Rectal Cancer
Clinical trial NCT07188025 · RECRUITING
Trial details
- NCT number
- NCT07188025
- Sponsor
- Erasmus Medical Center
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-14
- Primary completion
- 2030-10-01
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.